English

ContextVision Annual General Meeting

Report this content

On the 4th of May 2022, ContextVision held its ordinary Shareholders' Annual General Meeting in Stockholm.

Major items approved by the Annual General Meeting include:

  • The annual financial report regarding 2021 was approved by the AGM.
  • Disposition of financial results according to the proposal of the Board of Directors was approved.
  • The Managing Director and the Board of Directors were discharged from liability.
  • The Remuneration report for the Board of Directors and senior executives was approved.
  • Board compensation was decided according to the following:
    • The chairman of the board will be paid SEK 300.000 for the period until next AGM.
    • Other members of the board, whom are not also main shareholders, will be paid SEK 200.000 for the period until next AGM.
  • The audit fee will be based on current account.
  • Olof Sandén, Martin Hedlund, Sven Günther-Hanssen, Magne Jordanger and Martin Ingvar were reelected as board members. Olof Sandén was reelected as chairman of the board.
  • No deputy members were elected.
  • Grant Thornton was elected as auditor for the coming year, with acting auditor Joakim Söderin.

###

This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

###

For further information, please contact:

Markus Hökerberg (CFO)

tel +46 (0)8 7503550, e-mail markush@contextvision.se

About ContextVision

ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world.

Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment.

The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.

Subscribe

Documents & Links